The extensive observational study cohort comprised more than 540,000 adults, combining population data from Finland and the UK. Participants’ body mass indices (BMIs) were assessed initially, with follow-up periods averaging 13 to 14 years. This long-term monitoring enabled scientists to track the incidence of severe infectious diseases, defined as infections leading to hospital admissions or death. The findings consistently show a direct correlation between higher BMI and increased vulnerability to infections such as influenza, pneumonia, gastroenteritis, respiratory infections, and urinary tract infections.

Crucially, the risk did not plateau but rather escalated in tandem with increasing BMI. Individuals with severe obesity—defined as a BMI equal to or exceeding 40 kg/m²—were shown to experience a tripling in infection risk compared to those maintaining a BMI within the healthy range of 18.5 to 24.9 kg/m². To contextualize, UK Biobank participants with a healthy BMI had an annual risk of severe infection of approximately 1.1%, whereas those with obesity faced a risk of 1.8% annually, underlining the tangible impact on public health.

Delving into specific infection types, the study confirmed that obesity increases susceptibility not only to respiratory infections like COVID-19 and pneumonia but also to gastrointestinal infections and urinary tract infections. Interestingly, however, the data indicated no statistically significant increase in severe outcomes related to infections such as HIV or tuberculosis among obese individuals, suggesting that the immunological impairment linked to obesity may interact variably with different pathogens.

Globally, the implications of this research are staggering. By integrating infection mortality figures from the Global Burden of Diseases Study with obesity prevalence data, researchers estimate that approximately 10.8% of infectious disease deaths worldwide in 2023—amounting to some 600,000 fatalities—were attributable to obesity. This proportion varies markedly by country; for instance, obesity accounted for roughly one in four infectious disease deaths in the United States and one in six in the United Kingdom, highlighting the disproportionate burden in high-income nations with higher obesity rates.

The mechanistic underpinnings of this phenomenon likely involve obesity’s detrimental effects on the immune system. Adiposity is known to provoke chronic inflammation and impair immune cell function, which may compromise the body’s ability to mount effective responses against invading viruses, bacteria, and other pathogens. Moreover, the metabolic dysregulation characteristic of obesity, including insulin resistance and altered cytokine profiles, may exacerbate immune dysfunction, predisposing affected individuals to more severe infectious courses.

These findings have profound ramifications for public health and clinical practice. They emphasize the urgent need for comprehensive strategies that address obesity not only to mitigate chronic diseases like diabetes and cardiovascular conditions but also to curtail the rising toll of infectious diseases. Policy measures fostering access to affordable healthy foods, promoting physical activity, and supporting weight loss interventions must be prioritized. Additionally, healthcare providers should recognize the increased infectious risk in patients with obesity and ensure timely and appropriate immunization coverage to reduce preventable complications.

Researchers also spotlight the promise of emerging pharmacological interventions such as GLP-1 receptor agonists, which have demonstrated benefits for weight reduction and cardiovascular health. Preliminary evidence suggests these agents may also confer protection against severe infections by ameliorating obesity-associated immune impairments. Nonetheless, further research is needed to confirm these mechanisms and explore therapeutic avenues that could simultaneously address obesity and infection susceptibility.

While the study’s strengths include its extensive cohorts and long follow-up periods, limitations must be acknowledged. The observational nature precludes definitive causal inferences, and the cohorts from Finland and the UK may not perfectly represent global populations. Additionally, data from lower-resource settings may be less robust, necessitating cautious interpretation of global extrapolations. Future work should strive for broader population representation and mechanistic elucidation.

Professor Mika Kivimäki from University College London, who led the research, stresses the need to understand the broad biological pathways linking obesity to infectious disease risk. Given the anticipated global increase in obesity prevalence, the consequent rise in severe infections could pose a formidable challenge to healthcare systems worldwide. Addressing obesity thus emerges as a critical lever to improve resilience against infectious threats.

In sum, this landmark study extends our comprehension of obesity’s impact by illuminating its role as a substantial risk factor for severe infectious diseases beyond the scope of respiratory viruses alone. The findings underscore a pressing global health imperative to integrate obesity mitigation into infectious disease prevention frameworks and reinforce the vital importance of maintaining healthy body weight as a shield against severe infections.

Subject of Research: People

Article Title: Adult obesity and risk of severe infections: a multicohort study with global burden estimates

News Publication Date: 9-Feb-2026

Web References:
DOI link

References:

1. Galli M, Benenati S, Laudani C, et al. Cardiovasculareffectsand tolerability of GLP-1 Receptor agonists: a systematic review and meta-analysis of 99,599 patients. J Am CollCardiol2025; 86: 1805–19.
2. Global Burden of Diseases Study (details in the original paper).

Keywords: Obesity, Infectious diseases, Immunology, Epidemiology, Public health, BMI, Hospitalization, Mortality, Weight-loss drugs, Global health

Traditional epidermal thermometers often struggle to provide reliable readings when applied to hairy skin, where mounting devices securely and maintaining consistent contact are notoriously difficult. The new MET device addresses these obstacles by utilizing ultrafine microfiber structures, which conform intimately with the microscopic contours of the skin and navigate through hair follicles without causing discomfort or losing accuracy. This level of conformability ensures the sensor remains in place over extended durations, facilitating continuous monitoring that was previously unfeasible.

At the heart of this technology lies a sophisticated integration of flexible materials and sensitive thermal sensors, harmonized within a microfiber matrix. The microfiber scaffold acts as both a structural backbone and an interface that enhances thermal coupling with the skin surface. Unlike conventional squishy patches that often slip or degrade performance due to sweat or hair interference, the MET capitalizes on the structural integrity and permeability of microfibers, achieving a near-permanent bond that respects skin biomechanics. These properties allow the thermometer to function accurately over multiple days or even weeks without removal.

The design of MET involves intricate fabrication techniques that merge nanometer-scale conductive materials with breathable, skin-like substrates. This composite structure delivers a fine balance between mechanical robustness and flexibility, enabling the sensor to endure normal skin movements, stretching, and bending. Moreover, the sensor exhibits minimal thermal lag—meaning it can rapidly respond to temperature fluctuations, which is critical for detecting ephemeral systemic changes, such as during fever onset or inflammatory responses.

Another remarkable aspect of this research is the device’s ability to maintain precision in challenging environmental conditions. Hairy areas on the skin typically experience variable microclimates due to the presence of hair and glandular activity, factors that often confound temperature readings. The MET’s microfiber architecture naturally facilitates moisture wicking and ventilation, mitigating sweat accumulation that might otherwise distort thermal signals. Consequently, reliable and consistent temperature measurements have been demonstrated even in scenarios of intense physical activity or humid environments.

Extensive in vivo testing on human subjects was conducted to validate the MET’s performance across diverse skin types and body regions. Subjects reported exceptional comfort and no irritation during extended use, affirming the biocompatibility and breathability of the microfiber system. Importantly, data showed that temperature readings were not influenced by hair density or skin movement, underscoring the robustness of the design for practical clinical and daily life applications.

From a technological viewpoint, the MET device integrates seamlessly with wireless communication modules, enabling real-time data transmission to external monitoring systems. This capability opens avenues for its use in telemedicine, remote patient monitoring, and health tracking in everyday life. Healthcare providers can leverage continuous temperature data streams to make more informed diagnostic and therapeutic decisions, offering a more dynamic picture of a patient’s health status than periodic manual measurements.

The implications of this technology extend far beyond simple fever detection. Chronic conditions like diabetes, cardiovascular diseases, and dermatological disorders could benefit from continuous epidermal temperature surveillance, as temperature anomalies often correlate with disease progression or flare-ups. Moreover, by enabling long-term adherence and comfort, MET facilitates longitudinal studies on human thermoregulation and metabolic health, areas that have been previously limited by sensor design constraints.

From the engineering perspective, the researchers achieved a remarkable feat by balancing all necessary parameters—sensor sensitivity, mechanical resilience, user comfort, and consistency on hairy surfaces—which are often mutually exclusive in conventional designs. The microfiber approach not only solves the practical issue of hair interference but also enhances sensor longevity, as the material resists fouling and mechanical wear over time.

This innovation is poised to revolutionize wearable health monitors, setting a new benchmark for epidermal sensors that combine high precision with user-centric design. Unlike bulky, short-term adhesive devices, the MET system’s sleek, textile-like feel invites continuous integration into daily wear, blurring the lines between healthcare technology and fashion. Its potential to empower both patients and clinicians with reliable, real-time health data is immense.

Furthermore, the research opens exciting future directions in the development of multifunctional wearable systems. By incorporating additional sensing modalities—such as hydration, pH, or biochemical markers—into this microfiber platform, comprehensive health monitoring suites could be realized in a single, comfortable epidermal patch. Such advancements would catalyze a paradigm shift in personalized and preventative medicine.

The challenges ahead will involve scaling production and ensuring compatibility across diverse populations and environments. However, given the robustness demonstrated, the research team envisions rapid translation from lab prototypes to commercial wearable devices. Partnerships with medical technology companies and textile manufacturers are anticipated to bring this promising technology to the mass market.

In the context of a rapidly aging global population and increasing emphasis on remote health management, the MET technology aligns perfectly with emerging healthcare needs. It represents a fusion of material science, biomedical engineering, and sensor technology that could dramatically improve quality of life and clinical outcomes.

As wearable technology continues to evolve, the microfiber epidermal thermometer represents a visionary leap, blending scientific ingenuity with practical necessity. It underscores the power of interdisciplinary research in overcoming complex biomedical engineering challenges, ultimately enhancing human health monitoring in ways once thought impossible.

In an era where data-driven healthcare is becoming paramount, such high-precision, durable, and user-friendly sensors provide the crucial link between physiological phenomena and actionable insights. The success of the MET device offers a tangible example of how nuanced engineering can be harnessed to solve real-world problems at an intimate human interface.

Future research will likely explore further miniaturization, integration with artificial intelligence algorithms for predictive health analytics, and expansion into other sensory modalities. Nonetheless, this microfiber epidermal thermometer stands today as a beacon of innovation—an extraordinary fusion of comfort, precision, and utility destined to transform continuous health monitoring paradigms worldwide.

Subject of Research: Epidermal sensors; wearable temperature monitoring; microfiber-based biosensors; continuous health monitoring on hairy skin.

Article Title: Microfiber epidermal thermometer (MET) with extraordinary high precision designed for long-term use on hairy skin.

Article References:

Hanif, A., Park, J., Kim, D. et al. Microfiber epidermal thermometer (MET) with extraordinary high precision designed for long-term use on hairy skin.
npj Flex Electron 9, 82 (2025). https://doi.org/10.1038/s41528-025-00464-x

Image Credits: AI Generated